University of Sheffield
Sheffield, United Kingdom
Ola Rominiyi studied medicine at the University of Manchester where he obtained a 1st Class Honours degree in Physiology & Pharmacology and completed a degree in Clinical Medicine graduating with Honours in 2011.
After completing House Officer posts in Cambridge, King’s Lynn and Oxford, in 2014, Ola secured a highly competitive neurosurgical training number in Sheffield. During his neurosurgical training Ola developed a strong interest in neuro-oncology research as a means towards reducing the devastation brain tumours cause patients and families. Supported by a Royal College of Surgeons and Neurocare Clinical PhD Fellowship, and Yorkshire’s Brain Tumour Charity (formerly BTRS), he was awarded a PhD in Molecular Neuro-Oncology in 2020.
During Ola’s PhD, under the supervision Dr Spencer Collis, he identified novel combination treatment strategies based on multimodal targeting of the DNA damage response in glioblastoma. He also developed new clinically- and surgically-relevant patient-derived cancer stem cell models to establish the Sheffield ‘Living Biobank’ of Glioblastoma. In 2021, Ola was awarded Sheffield’s first NIHR Clinical Lectureship in Neurosurgery which enables him to combine ongoing clinical training with research as Translational Lead for the newly established Sheffield Translational Brain Tumour Research Group.